Description: Come learn from a panel of LTC industry professionals as they discuss setting goals for LTC wellness, measuring success of the programs, and integrating them with other LTC process (e.g. assumption setting) in an effort to create sustainable programs.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: Learn from panelists from different companies as they come together to discuss their experiences.

Description: Learn how modernization of data, models, and technology are influencing workflows. This webcast will address how workflows are changing in response to new regulatory requirements and the impacts the changes have on modeling and end-to-end future state operating models. Industry leading actuaries will discuss: How team collaboration can increase quality and speed of reporting to internal and external stakeholders How to strengthen controls and compliance frameworks across finance and actuarial departments How to modernize actuarial input/output for strategic analysis and insights How to attract and retain top talent by improving opportunities for actuaries There will also be dedicated time to ask questions of those who have made the transition.

Description: The session begins with a brief introduction to Gen AI, including “what it is” and how to optimize outputs. Then, we will to provide some insight into what we are seeing within the Actuarial space – this would include the extent to which actuaries are using Gen AI on a day-to-day basis, how they are going about using it, and some predictions as to where this will go.

Description: The session begins with a brief introduction to Gen AI, including “what it is” and how to optimize outputs.Then, we will to provide some insight into what we are seeing within the Actuarial space – this would include the extent to which actuaries are using Gen AI on a day-to-day basis, how they are going about using it, and some predictions as to where this will go. Finally, we will dive into specific actuarial use cases – we have a few bespoke built actuarial demonstrations to show and will supplement this with a discussion on the broader spectrum of actuarial use cases. We plan for this to be the bulk of the session.

Description: This session will examine bias from a social science perspective. It will discuss the three types of systemic biases using the National Institute of Standards and Technology (NIST) model. The NIST model details the three types as historical bias, societal bias, and institutionalbias. The session will also provide several examples of each type to provide a framework for identifying the social structure of bias.

Description: Gather with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, pension, investment, product strategy, and more.